dactinomycin has been researched along with 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, FM; Mullins, TD; Newman, RA; Rose, KM; Wassermann, K | 1 |
Acton, EM; Andersson, BS; Bakic, M; Mullins, TD; Newman, RA; Silberman, LE; Wassermann, K; Zwelling, LA | 1 |
2 other study(ies) available for dactinomycin and 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin
Article | Year |
---|---|
Selective inhibition of human ribosomal gene transcription by the morpholinyl anthracyclines cyanomorpholinyl- and morpholinyldoxorubicin.
Topics: Dactinomycin; Doxorubicin; Fluorescent Antibody Technique; HeLa Cells; Humans; Microscopy, Electron; Ribosomes; RNA Polymerase I; Transcription, Genetic | 1988 |
Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.
Topics: Antibiotics, Antineoplastic; Cell Nucleolus; Cell Survival; Cells, Cultured; Dactinomycin; DNA, Neoplasm; Doxorubicin; Humans; Leukemia; RNA, Neoplasm; Structure-Activity Relationship | 1986 |